FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38620511000001103: Carbocisteine 250mg/5ml oral solution sugar free 300 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jul 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1391151000001112 Carbocisteine 250mg/5ml oral solution sugar free 300 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1391161000001110 Carbocisteine 250mg/5ml oral solution sugar free 300 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Has VMP Carbocisteine 250mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free 300 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 250mg/5ml oral solution sugar free (DE Pharmaceuticals) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Lucis Pharma Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Roma Pharmaceuticals Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Brown & Burk UK Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution sugar free 300 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start